InMode Ltd., a leading global provider of medical technologies, is all set to participate in the highly esteemed 23rd Annual Needham & Company Virtual Healthcare Conference on April 9, 2024. Representing InMode at this prestigious event is Dr. Spero Theodorou, M.D., the company’s Chief Medical Officer and the founder and Surgical Director of bodySCULPT®. Alongside Moshe Mizrahy, Chief Executive Officer and Chairman, and Yair Malca, Chief Financial Officer, Dr. Theodorou will engage in a virtual fireside chat moderated by Senior Equity Research Analyst Mike Matson, CFA. This discussion aims to explore InMode’s innovative technologies, strategic vision, financial performance, and plans for future growth. Additionally, the conference offers one-on-one meetings, providing attendees with direct access to InMode’s leadership team, fostering deeper insights into the company’s business model, product pipeline, and market positioning.
*Disclaimer: The materials on this website are for informational purposes only and do not constitute the giving of medical advice. Individual results will vary and no guarantee is stated or implied by any photo use or any statement on this site. Your use of this site does not create a patient-plastic surgeon relationship between you and bodySCULPT® or between you and any plastic surgeon affiliated with bodySCULPT®. The information contained in this website is not intended to be a substitute for professional medical advice. Click Here for Full Disclaimer.
Copyright © 2024 body SCULPT®. All Rights Reserved. Website Design / SEO by MedResponsive